A5041801140- Cancer Immunotherapy and Biomarkers
- Ferroptosis and cancer prognosis
- Urinary Bladder and Prostate Research
- Pediatric Urology and Nephrology Studies
- Cancer Genomics and Diagnostics
- Bone and Joint Diseases
- Traumatic Brain Injury and Neurovascular Disturbances
- Bladder and Urothelial Cancer Treatments
- Intracerebral and Subarachnoid Hemorrhage Research
- Kidney Stones and Urolithiasis Treatments
Affiliated Hospital of Nantong University
2022-2023
Nantong University
2022-2023
Abstract Background The objective of this research was to examine the impact monocyte-to-lymphocyte ratio (MLR) on advancement hematoma after cerebral contusion. Methods clinical information and laboratory test findings people with contusion were retrospectively analyzed. Using tertiles MLR, study participants categorized into three groups, enabling evaluation correlation between MLR Results Among cohort patients showing progression, levels significantly higher compared nonprogress group ( P...
In recent years, more and reports have shown that GINS complex subunit 2 (GINS2) plays an important role in the occurrence progression of tumours. However, there is a lack comprehensive systematic research on its prognostic immune effects pan-cancer. Therefore, this study aimed at investigating value immune-related GINS2 human tumours providing understanding carcinogenic mechanism We investigated different databases, including TIMER, TCGA, GTEX, CPTAC, GEPIA, SangerBox. The was carried out...
Abstract Background BLCA is the second most common urogenital malignancy. In recent years, although use of neoadjuvant and adjuvant chemotherapy has been thoroughly studied, prognosis metastatic still poor. order to improve survival patients accuracy their response individualized therapy, we need further explore more novel biomarkers.Immunogenic cell death (ICD), a unique form regulatory death, not only plays an important role in immune process, but also activates adaptation immunocompetent...